Nazmul MN et al. |
Severe Hyperkalemia Complicating Voriconazole Treatment in a Kidney Transplant Recipient With Histoplasmosis: A Case Report. |
2017 |
Transplant. Proc. |
pmid:29198681
|
Berisa Prado S et al. |
Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis. |
2017 |
Cornea |
pmid:28704319
|
Hirai T et al. |
The effectiveness of new triple combination therapy using synthetic disease-modifying anti-rheumatic drugs with different pharmacological function against rheumatoid arthritis: the verification by an in vitro and clinical study. |
2017 |
Clin. Rheumatol. |
pmid:27783236
|
Ruiz S et al. |
Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology. |
2017 |
Hum. Mol. Genet. |
pmid:28973643
|
Zhu J et al. |
Granzyme B producing B-cells in renal transplant patients. |
2017 |
Clin. Immunol. |
pmid:28461110
|
Terada Y et al. |
Tacrolimus Triggers Transient Receptor Potential Vanilloid-1-Dependent Relapse of Pancreatitis-Related Pain in Mice. |
2017 |
Pharmacology |
pmid:28253495
|
Kaneshiro S et al. |
The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab. |
2017 |
Mod Rheumatol |
pmid:27181115
|
Reese PP et al. |
Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial. |
2017 |
Am. J. Kidney Dis. |
pmid:27940063
|
Božina N et al. |
Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients' and donors' ABCC2 gene variants, and their interactions. |
2017 |
Eur. J. Clin. Pharmacol. |
pmid:28624888
|
Hasegawa M et al. |
Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus. |
2018 |
J. Dermatol. |
pmid:29265410
|
Shuker N et al. |
Intrapatient Variability in Tacrolimus Exposure Does Not Predict The Development of Cardiac Allograft Vasculopathy After Heart Transplant. |
2018 |
Exp Clin Transplant |
pmid:28969528
|
Huang F et al. |
Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover Study. |
2018 |
Basic Clin. Pharmacol. Toxicol. |
pmid:29427400
|
González-VÃlchez F et al. |
Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation. |
2018 |
Rev Esp Cardiol (Engl Ed) |
pmid:28545984
|
Al-Lawati H et al. |
Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research. |
2018 |
Expert Opin Drug Deliv |
pmid:29261332
|
Tillmann FP et al. |
Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up. |
2018 |
Int Urol Nephrol |
pmid:29197933
|
Thoms S et al. |
Tacrolimus inhibits angiogenesis and induces disaggregation of endothelial cells in spheroids - Toxicity testing in a 3D cell culture approach. |
2018 |
Toxicol In Vitro |
pmid:30048735
|
Lee KH et al. |
Distribution of Anti-ABO Immunoglobulin G Subclass and C1q Antibody in ABO-incompatible Kidney Transplantation. |
2018 |
Transplant. Proc. |
pmid:29731066
|
Htun YY et al. |
CYP3A5*3 Genetic Polymorphism and Tacrolimus Concentration in Myanmar Renal Transplant Patients. |
2018 |
Transplant. Proc. |
pmid:29731062
|
Hu R et al. |
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation. |
2018 |
Basic Clin. Pharmacol. Toxicol. |
pmid:29603629
|
Schuh MJ and Massoglia G |
Pharmacist Impact on Tacrolimus Serum Concentrations in Liver Transplant Patients. |
2018 |
Consult Pharm |
pmid:29789048
|